Valuation: Coral Laboratories Limited

Market Cap 1.32B 13.88M 12.14M 11.19M 10.35M 19.67M 20M 134M 52.49M 651M 52.11M 50.97M 2.25B P/E 2024
8.4x
P/E 2025 10.4x
Enterprise Value 1.05B 11.01M 9.63M 8.88M 8.21M 15.6M 15.86M 106M 41.63M 516M 41.33M 40.43M 1.79B EV / Sales 2024
1.25x
EV / Sales 2025 1.94x
Free-Float
19.98%
Yield 2024
0.54%
Yield 2025 0.21%
1 day+2.17%
1 week-3.21%
Current month-4.71%
1 month+18.51%
3 months+46.97%
6 months+29.66%
Current year+34.30%
1 week 570.75
Extreme 570.75
620
1 month 475
Extreme 475
659
Current year 360
Extreme 360
659
1 year 360
Extreme 360
659
3 years 230
Extreme 230
999
5 years 217
Extreme 217
999
10 years 81.2
Extreme 81.2
1,190
Manager TitleAgeSince
Director of Finance/CFO 49 26/05/2017
Director TitleAgeSince
Director/Board Member 45 26/05/2017
Director/Board Member 49 26/05/2017
Director/Board Member 40 28/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
+2.17%-3.21%-0.19%+142.35% 21.51M
+0.09%+2.12%+56.49%+169.19% 1,084B
-1.63%+2.02%+66.31%+62.70% 634B
-1.12%-0.46%+31.69%+84.44% 447B
+0.18%+2.04%+30.19%+26.51% 330B
-6.22%-3.61%+29.15%+32.09% 295B
-1.27%-0.56%+27.21%+46.39% 285B
-0.93%-1.19%-28.85%-40.38% 218B
-1.19%+0.63%+22.43%+66.30% 199B
-0.72%+7.04%+21.41%+81.19% 169B
Average -0.72%+1.74%+25.59%+67.08% 365.99B
Weighted average by Cap. -0.58%+2.48%+39.76%+84.80%

Financials

2024 2025
Net sales 837M 8.77M 7.67M 7.07M 6.54M 12.43M 12.64M 84.74M 33.17M 411M 32.93M 32.21M 1.42B 1.15B 12.06M 10.54M 9.72M 8.99M 17.09M 17.37M 116M 45.6M 565M 45.27M 44.28M 1.96B
Net income 158M 1.66M 1.45M 1.34M 1.23M 2.35M 2.38M 15.99M 6.26M 77.63M 6.21M 6.08M 269M 242M 2.53M 2.21M 2.04M 1.89M 3.59M 3.65M 24.47M 9.58M 119M 9.51M 9.3M 411M
Net Debt -278M -2.91M -2.55M -2.35M -2.17M -4.13M -4.2M -28.14M -11.02M -137M -10.94M -10.7M -473M -274M -2.87M -2.51M -2.32M -2.14M -4.07M -4.14M -27.74M -10.86M -135M -10.78M -10.55M -466M
Logo Coral Laboratories Limited
Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.
Employees
197
Date Price Change Volume
09/07/26 INR 588.90 +2.17% 370
08/07/26 INR 576.40 -4.05% 1,105
07/07/26 INR 600.75 -2.24% 501
06/07/26 INR 614.50 +1.48% 322
03/07/26 INR 605.55 +0.25% 945
  1. Stock Market
  2. Stocks
  3. CORALAB6 Stock